Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

JJV McMurray*, FL Andersson, S Stewart, K Svensson, AC Solal, R Dietz, J Vanhaecke, DJ van Veldhuisen, J Ostergren, CB Granger, S Yusuf, MA Pfeffer, K Swedberg, CHARM Investigators and Comm

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)
243 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases